Top Markets
Coin of the day
Ortin Laboratories Limited Ortin Laboratories Limited

Ortin Laboratories Limited

ORTINLAB
Classificação em ações #37115
Ortin Laboratories Limited, a pharmaceutical company established in Hyderabad,... Ortin Laboratories Limited, a pharmaceutical company established in Hyderabad, India, in 1986, is engaged in the manufacturing and commercialization of a diverse range of medicines, drugs, and chemical intermediates. The company provides a wide array of pharmaceutical formulations, presented as tablets, capsules, syrups, and dry powders. These products target various therapeutic domains such as metabolic diseases (e.g., anti-diabetics), allergic reactions, infections (including broad-spectrum antibiotics and antifungals like quinolones, penicillins, cephalosporins, macrolides, and antifungals), pain management and fever reduction (analgesics and antipyretics), cardiovascular ailments (anti-anginal and cardiovascular products), digestive system disorders (antacids and anti-ulcerants), neurological and psychiatric conditions (sedatives, tranquilizers, psychiatry products), and nutritional supplementation (like vitamins, calcium, iron, and protein supplements). Specialized offerings also include anti-retroviral, anti-arthritic, anti-helminthic, anti-spasmodic, gynaec, appetite stimulators, and chemotherapeutic preparations. In addition to finished pharmaceuticals, Ortin produces active pharmaceutical ingredient (API) intermediates for applications such as anti-retrovirals, anti-diabetics, pain and fever medications, antibiotics, antifungals, antacids, anti-malarials, and anti-ulcerants. Its manufacturing capabilities also extend to fine chemicals and Grignard/alkali metal compounds. The company offers specialized services covering process development and characterization, analytical research, assay development, and product characterization. It also contributes to diagnostics through the development of rapid flow kits, assays, and reagents. Ortin Laboratories undertakes long-term contracts for the production of intermediates and the creation of novel APIs. Moreover, it actively functions as a merchant exporter of its finished pharmaceutical products.
Preço da ação
$0.2488447
Última sincronização: 2024-10-01
Valor de mercado
$2.01M
Variação (1 dia)
-1.88%
Variação (1 ano)
0.00%
País
IN
Negociar Ortin Laboratories Limited (ORTINLAB)

Categoria

Receita da Ortin Laboratories Limited (ORTINLAB)
Receita em Jun 2024 TTM: $89.95K
De acordo com os últimos relatórios financeiros da Ortin Laboratories Limited, a receita atual da empresa (TTM) é $89.95K. Em 2023, a empresa obteve uma receita de $732.57K uma diminuição em relação a a receita do ano 2022, que foi de $1.08M. A receita é o valor total gerado pela venda de bens ou serviços. Ao contrário do lucro, nenhuma despesa é subtraída.
Histórico de receita da Ortin Laboratories Limited de 2008 a 2026
Receita no final de cada ano
Ano Receita Alterar
2026 (TTM) $89.95K -64.48%
2024 $253.23K -65.43%
2023 $732.57K -32.44%
2022 $1.08M -2.82%
2021 $1.12M -95.72%
2020 $26.04M 10.75%
2019 $23.51M 92.06%
2018 $12.24M 87.73%
2017 $6.52M 8.62%
2016 $6.00M -4.55%
2015 $6.29M -33.47%
2014 $9.45M -12.98%
2013 $10.86M -35.79%
2012 $16.92M 20.37%
2011 $14.06M 101.43%
2010 $6.98M 19.15%
2009 $5.86M -19.40%
2008 $7.27M 0.00%
Receita de empresas similares ou concorrentes